WO2007012066A3 - TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF - Google Patents
TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF Download PDFInfo
- Publication number
- WO2007012066A3 WO2007012066A3 PCT/US2006/028323 US2006028323W WO2007012066A3 WO 2007012066 A3 WO2007012066 A3 WO 2007012066A3 US 2006028323 W US2006028323 W US 2006028323W WO 2007012066 A3 WO2007012066 A3 WO 2007012066A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- truncated
- derivatives
- oxidized thymosin
- thymosin
- oxidized
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57581—Thymosin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06788075A EP1913013A2 (en) | 2005-07-19 | 2006-07-19 | Truncated oxidized thymosin beta4 and derivatives thereof |
AU2006269852A AU2006269852A1 (en) | 2005-07-19 | 2006-07-19 | Truncated oxidized thymosin beta4 and derivatives thereof |
CA002616125A CA2616125A1 (en) | 2005-07-19 | 2006-07-19 | Truncated oxidized thymosin .beta.4 and derivatives thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70064105P | 2005-07-19 | 2005-07-19 | |
US60/700,641 | 2005-07-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007012066A2 WO2007012066A2 (en) | 2007-01-25 |
WO2007012066A3 true WO2007012066A3 (en) | 2007-06-07 |
Family
ID=37669572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/028323 WO2007012066A2 (en) | 2005-07-19 | 2006-07-19 | TRUNCATED OXIDIZED THYMOSIN β4 AND DERIVATIVES THEREOF |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1913013A2 (en) |
AU (1) | AU2006269852A1 (en) |
CA (1) | CA2616125A1 (en) |
WO (1) | WO2007012066A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009151689A2 (en) * | 2008-03-17 | 2009-12-17 | Regenerx Biopharmaceuticals, Inc. | Improved beta thymosin fragments |
EP2382231A2 (en) * | 2009-01-16 | 2011-11-02 | Sederma | New compounds, in particular peptides, compositions comprising them and cosmetic and dermopharmaceutical uses |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602519B1 (en) * | 1998-03-28 | 2003-08-05 | The University Court Of The University Of Glasgow | Oxidized thymosin β4 |
-
2006
- 2006-07-19 CA CA002616125A patent/CA2616125A1/en not_active Abandoned
- 2006-07-19 AU AU2006269852A patent/AU2006269852A1/en not_active Abandoned
- 2006-07-19 EP EP06788075A patent/EP1913013A2/en not_active Ceased
- 2006-07-19 WO PCT/US2006/028323 patent/WO2007012066A2/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602519B1 (en) * | 1998-03-28 | 2003-08-05 | The University Court Of The University Of Glasgow | Oxidized thymosin β4 |
Non-Patent Citations (1)
Title |
---|
GONDO H. ET AL.: "Differential expression of the human thymosin-beta 4 gene in lymphocytes, macrophages, and granulocytes", J. IMMUNOL., vol. 139, no. 11, 1 December 1987 (1987-12-01), pages 3840 - 3848, XP003013717 * |
Also Published As
Publication number | Publication date |
---|---|
CA2616125A1 (en) | 2007-01-25 |
AU2006269852A1 (en) | 2007-01-25 |
EP1913013A2 (en) | 2008-04-23 |
WO2007012066A2 (en) | 2007-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
WO2005116088A3 (en) | Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells | |
WO2006068729A3 (en) | Methods and compositions for enhancing iron absorption | |
MX2007010560A (en) | Roflumilast for the treatment of diabetes mellitus. | |
EP1912650B8 (en) | Use of flibanserin in the treatment of obesity | |
PL1909843T3 (en) | Antitumoral bioconjugates of hyaluronic acid or its derivatives obtained by indirect chemical conjugation, and their use in the pharmaceutical field | |
CL2007002261A1 (en) | COMPOUNDS DERIVED FROM IMIDAZO [1,2-B] PIRIDAZINA, QUINASA INHIBITORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PREVENTION OF CANCER. | |
EP2335722A3 (en) | Use of gelsolin to treat infections | |
WO2005123116A3 (en) | Compositions and methods for treating or preventing oxalate-related disease | |
WO2004071382A3 (en) | Substituted heterocycles | |
WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
IL178390A0 (en) | Methods and compositions for the treatment, prevention or management of dysfunctional sleep and dysfunctional sleep associated with disease | |
WO2007070052A3 (en) | Pharmaceutical compositions and methods for treating or preventing oxalate-related disease | |
MY147247A (en) | Organic compounds and their uses | |
IL220682A0 (en) | 1h-quinazoline-2,4-diones, processes for their manufacture, and use thereof in the preparation of medicaments for treating conditions mediated by the ampa-receptor | |
WO2005037323A3 (en) | Use of gro to treat or prevent inflammation | |
WO2004041269A3 (en) | New use for pharmaceutical composition | |
WO2005094554A3 (en) | Therapeutic agents, methods, and treatments | |
CL2007003038A1 (en) | COMPOUNDS DERIVED FROM 2-PHENYL-6-AMINOCARBONIL-PYRIMIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS. | |
WO2009156182A3 (en) | Uracil derivatives and use thereof | |
EP1978983A4 (en) | Extract of dioscorea sp. and the medical uses thereof | |
WO2007129114A3 (en) | Aptamers directed to recombinant muc1 | |
WO2007144057A3 (en) | Antimicrobial carbon | |
IL194880A (en) | Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them | |
WO2007041614A3 (en) | Long acting vegf inhibitors and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2616125 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006269852 Country of ref document: AU |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006788075 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006269852 Country of ref document: AU Date of ref document: 20060719 Kind code of ref document: A |